British drugmaker GlaxoSmithKline Plc said on Sept. 5 it would cut about 650 positions in the United States related to a global restructuring program it announced in July.
The job cuts would include about 100 each in its back office in Philadelphia and at Research Triangle Park, North Carolina, and 450 sales representatives, GlaxoSmithKline spokeswoman Mary Anne Rhyne said in a statement.
